BackLucid Diagnostics Overview
Lucid Diagnostics Inc

Lucid Diagnostics Target Price

Where could LUCD trade next? Consensus target price: $2.

Get informed when a big investor buys or sells

+ Follow

Share Price

$0.95

Average Target Price

$2.00110.3% upside

1 analysts in the last 4 months

High: $2 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-15Maxim Group$2110.3% upsideOpen
2025-03-25BTIG$2110.3% upsideOpen
2024-11-13NeedhamMike Matson$2.5162.8% upsideOpen
2024-05-14Canaccord GenuityKyle Mikson$3215.4% upsideOpen
2024-04-08BTIGMark Massaro$2.5162.8% upsideOpen
2022-11-18BTIG$3.5268% upsideOpen
2022-11-15Needham$3.1225.9% upsideOpen

Lucid Diagnostics (LUCD) FAQ

Lucid Diagnostics posts a target price of $2. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $2 for LUCD means covering analysts, on average, see the stock 110.3% upside of $0.95 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for LUCD's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Lucid Diagnostics's other metric pages and overview cover the third.